Dr Parvinder Punia, senior regulatory affairs manager, ELC Group, discusses the use of guidelines in drug development
As costs of development escalate and guidelines grow, the need for scientific advice from regulators becomes an essential part of any drug development timeline. As guidelines are open to interpretation, the basis of the scientific reasoning should be open for debate. In this way, many guidelines have gone through evolutions.